Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while...
In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.
In his last video, Garret Duron, MD, explained which questions rheumatologists can ask themselves when determining whether a piece of COVID-19 literature will be helpful to them. But what information would...